BA
TTRX

Bridgewater Advisors’s Turn Therapeutics TTRX Stock Holding History

Bridgewater Advisors’s Portfolio TTRX Stock Details TTRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$242K Buy
+27,326
New +$127K 0.01% 426

Other funds holding TTRX

SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
DI
DDFG Inc Thousand Oaks, California $504M AUM 18.61% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $1.07B AUM 26.86% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
RW
RVW Wealth Los Angeles, California $1.52B AUM 23.06% 1-Year Est. Return
MMA
Miracle Mile Advisors Los Angeles, California $8.53B AUM 21.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
CFS
Cannon Financial Strategists Athens, Georgia $879M AUM 22.04% 1-Year Est. Return

Bridgewater Advisors's TTRX Position: Q2 2026 in Review

Bridgewater Advisors opened a new position in Turn Therapeutics (TTRX) in Q2 2026: 27,326 shares worth $242K. The stake represents 0.01% of the portfolio and ranks #426 among its holdings.

14 funds tracked by Wall St. Rank hold TTRX as of Q2 2026.

  • Bridgewater Advisors held 27,326 shares of Turn Therapeutics worth $242K as of Q2 2026.
  • Turn Therapeutics was a new Bridgewater Advisors position in Q2 2026.
  • Turn Therapeutics made up 0.01% of Bridgewater Advisors's portfolio in Q2 2026, its #426 holding.
  • 14 funds tracked by Wall St. Rank held Turn Therapeutics as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.